New patent expiration for Novartis drug TYZEKA

Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…

The post New patent expiration for Novartis drug TYZEKA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.